INV 27 Phase I trial of sorafenib (BAY 43-9006) combined with dacarbazine (DTIC) in patients with metastatic melanoma
- 1 February 2007
- journal article
- Published by Wolters Kluwer Health in Melanoma Research
- Vol. 17 (1) , A12-A13
- https://doi.org/10.1097/00008390-200702000-00037